Navigation Links
Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems

BOTHELL, Wash., April 1, 2008 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced today that it signed a letter of intent to begin establishing Heartcentrix(R) ECG connectivity with the Misys MyWay(TM) electronic medical record (EMR) system from Misys Healthcare.


Misys Healthcare serves more than 100,000 physicians in 18,000 practice locations. "Misys MyWay integrates EMR, practice management, and claims management to offer a simple, affordable, complete solution for physicians and clinicians," Paul Edge, Vice President, Clinical Solutions for Misys Healthcare said. "With this agreement, thousands of our customers have the potential to access information from new or currently installed Burdick and Quinton electrocardiograph (ECG) devices, stress systems, and Holter devices while using our Misys MyWay EMR systems."

The HeartCentrix solution from Cardiac Science helps bring patient history, clinical charting, e-prescribing, lab orders, results, and patient follow-up information together into a single EMR application. "We designed HeartCentrix to streamline diagnostic cardiology workflow," said Greg Newman, senior marketing manager for Cardiac Science. "Ultimately, the patient benefits. With streamlined integration, physicians have easier access to information, faster results, and fewer chances for operator error, patients receive a higher standard of care."

Tony Titus, Cardiac Science vice president of marketing added, "The agreement with Misys Healthcare is another step in our goal to connect our diagnostic cardiology products seamlessly with all major EMR solution providers. We're very much looking forward to this partnership."

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit

About Misys Healthcare Systems, LLC

Misys Healthcare -- part of the global application software and services company, Misys plc (FTSE: MSY.L) -- delivers integrated, comprehensive solutions that improve results for healthcare practitioners. Drawing on our decades of healthcare experience, our relationships with more than 100,000 healthcare professionals, and our commitment to customer success, we deliver innovative software and services that enable physicians, caregivers, and a connected healthcare community. Misys Healthcare: Experience, Solutions, Results. Contact us today; visit

Forward Looking Statements

This press release contains forward-looking statements. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Forward looking statements in this press release include those that infer or imply that the revenue and profits of Cardiac Science may increase as a result of the connectivity of its products with those of Misys, as well as other risks that are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2006. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

Company Contact: Investor Contact: Media Contact:

Mike Matysik Jenifer Kirtland Christopher Gale

Cardiac Science Corporation EVC Group, Inc. EVC Group, Inc.

Sr. Vice President and CFO (415) 896-6820 (201) 646-5431

(425) 402-2009 (203) 570-4681 CSCX - G

SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness
2. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
3. New research shows that iPods do not interfere with cardiac pacemakers
4. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
5. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
6. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
7. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
8. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
9. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
10. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Thomson Scientific Begins Expansion of Web of Science
Post Your Comments:
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
(Date:11/24/2015)... ... November 24, 2015 , ... The United States Golf Association (USGA) today announced ... Section Award. Presented annually since 1961, the USGA Green Section Award recognizes an individual’s ... , Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an ... is bound to proteins, copper is also toxic to cells. With a $1.3 ... Institute (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/19/2015)... Nov. 19, 2015  Based on its in-depth analysis ... recognizes BIO-key with the 2015 Global Frost & Sullivan ... & Sullivan presents this award to the company that ... the needs of the market it serves. The award ... and expands on customer base demands, the overall impact ...
(Date:11/19/2015)... 2015  Although some 350 companies are actively involved ... few companies, according to Kalorama Information. These include Roche Diagnostics, ... market share of the 6.1 billion-dollar molecular testing market, ... for Molecular Diagnostic s .    ... controlled by one company and only a handful of ...
Breaking Biology News(10 mins):